25 May 2013
Keywords: fda, rejects, merck, co, arcoxia, calls, additional
Article | 07 May 2007
The US Food and Drug Administration has rejected drug major Merck & Co's controversial drug for the symptoms of osteoathritis Arcoxia
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
7 May 2007
24 May 2013
© 2013 thepharmaletter.com